Back to funds

Paradigm Biocapital Advisors LP

Updated 6 days ago

Managed by Paradigm Biocapital Advisors Lp • Latest filing Q3 2026

Portfolio value
$5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$3.9B
Q1 2026$4.9B
Q2 2026$5.3B
Q3 2026$5B

Top holdings

30 positions as of Q3 2026

View filing
R

REVOLUTION MEDICINES INC

Value
$1.3B
Shares
6.22M
% Port
25.38%
G

GENMAB A/S

Value
$504.3M
Shares
14.14M
% Port
10.03%
E

EDGEWISE THERAPEUTICS INC

Value
$437.6M
Shares
10.78M
% Port
8.70%
S

SPYRE THERAPEUTICS INC

Value
$396.8M
Shares
4.46M
% Port
7.89%
I

INSMED INC

Value
$307.7M
Shares
2.70M
% Port
6.12%
M

MBX BIOSCIENCES INC

Value
$221.2M
Shares
3.77M
% Port
4.40%
O

ORUKA THERAPEUTICS INC

Value
$207.7M
Shares
2.49M
% Port
4.13%
B

BELITE BIO INC

Value
$194M
Shares
1.14M
% Port
3.86%
T

TARSUS PHARMACEUTICALS INC

Value
$180.9M
Shares
2.30M
% Port
3.60%
T

TANGO THERAPEUTICS INC

Value
$173.7M
Shares
6.96M
% Port
3.45%
V

VIRIDIAN THERAPEUTICS INC

Value
$170M
Shares
8.26M
% Port
3.38%
B

BRIDGEBIO PHARMA INC

Value
$154.5M
Shares
2.35M
% Port
3.07%
P

VAXCYTE INC

Value
$121.9M
Shares
2.14M
% Port
2.42%
E

ERASCA INC

Value
$117.3M
Shares
8.00M
% Port
2.33%
J

JADE BIOSCIENCES INC

Value
$85M
Shares
6.05M
% Port
1.69%
T

TYRA BIOSCIENCES INC

Value
$76.8M
Shares
3.51M
% Port
1.53%
O

OLEMA PHARMACEUTICALS INC

Value
$75.3M
Shares
8.72M
% Port
1.50%
O

OBSIDIAN THERAPEUTICS INC

Value
$57.1M
Shares
4.16M
% Port
1.13%
G

STRUCTURE THERAPEUTICS INC

Value
$40.6M
Shares
1.30M
% Port
0.81%
A

ACHIEVE LIFE SCIENCE INC

Value
$40.1M
Shares
4.95M
% Port
0.80%

Explore